Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3329-3334

  Song, Hannah ^a   Yoon, Charles ^a   Kattman, Steven J ^b   Dengler, Jana ^a,c   Massé, Stéphane ^d   Thavaratnam, Thushaanthini ^c   Gewarges, Mena ^c   Nanthakumar, Kumaraswamy ^d   Rubart, Michael ^e   Keller, Gordon M ^b   Radisic, Milica ^a,c,f   Zandstra, Peter W ^a,b,c,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HEART AND STROKE FOUNDATION OF CANADA   (Canada)

Author keywords

Cardiac progenitor; Cell therapy; Engineered heart tissue; Myocardial infarction; Regenerative medicine

Indexed keywords

CONNEXIN 43;

ANIMAL CELL; ARTICLE; BIOREACTOR; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTROPHYSIOLOGY; EMBRYO; EMBRYONIC STEM CELL; FETUS; FIBROBLAST; HEART; HEART MUSCLE CELL; IN VIVO STUDY; INJECTION; MODEL; MOUSE; NEWBORN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCREENING; VALIDATION STUDY;

ANIMALS; BIOREACTORS; CELL DIFFERENTIATION; CONNEXIN 43; ELECTROPHYSIOLOGICAL PROCESSES; FIBROBLASTS; HEART FAILURE; MICE; MICE, TRANSGENIC; MYOBLASTS, CARDIAC; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING;

EID: 77649248002     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905729106     Document Type: Article

References (43)

1. Anonymous (2004) WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci 58:405-406.
2. Dengler TJ, Katus HA (2002) Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty"). Herz 27:598-610.
3. Snir M, et al. (2003) Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285:H2355-2363.
4. Fijnvandraat AC, et al. (2003) Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol 35:1461-1472.
5. Kehat I, et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407-414.
6. Zandstra PW, et al. (2003) Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9:767-778.
7. Bauwens C, Yin T, Dang S, Peerani R, Zandstra PW (2005) Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: Oxygenmediated enhancement of cardiomyocyte output. Biotechnol Bioeng 90:452-461.
8. Klug MG, Soonpaa MH, Koh GY, Field LJ (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98:216-224.
9. Kattman SJ, Huber TL, Keller GM (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11:723-732.
10. Moretti A, et al. (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151-1165.
11. Wu SM, et al. (2006) Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127:1137-1150.
12. Kroon E, et al. (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443-452.
13. Zhang D, et al. (2009) Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 19:429-438.
14. Radisic M, et al. (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 101:18129-18134.
15. Radisic M, et al. (2008) Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A 86:713-724.
16. Koh GY, et al. (1995) Stable fetal cardiomyocyte grafts in the hearts of dystrophicmice and dogs. J Clin Invest 96:2034-2042.
17. Skobel E, et al. (2004) Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng, 10:849-864, 2004.
18. van der Bogt KE, et al. (2009) Comparison of transplantation of adipose tissue- and bone marrow-derivedmesenchymal stemcells in the infarcted heart. Transplantation 87:642-652.
19. Mummery C, et al. (2002) Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat 200:233-242.
20. Kolossov E, et al. (1998) Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 143:2045-2056.
21. Cheng M, Park H, Engelmayr GC, Moretti M, Freed LE (2007) Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Eng 13:2709-2719.
22. Yu J, et al. (2006) Insulin improves cardiomyocyte contractile function through enhancement of SERCA2a activity in simulated ischemia/reperfusion. Acta Pharmacol Sin 27:919-926.
23. Jovanovic S, Jovanovic N, Jovanovic A (2006) High glucose protects single beating adult cardiomyocytes against hypoxia. Biochem Biophys Res Commun 341:57-66.
24. Sharma S, Guthrie PH, Chan SS, Haq S, Taegtmeyer H (2007) Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart. Cardiovasc Res 76:71-80.
25. Saffitz JE, Kanter HL, Green KG, Tolley TK, Beyer EC (1994) Tissue-specific determinants of anisotropic conduction velocity in canine atrial and ventricular myocardium. Circ Res 74:1065-1070.
26. Hirata H, et al. (2007) Coexpression of platelet-derived growth factor receptor alpha and fetal liver kinase 1 enhances cardiogenic potential in embryonic stem cell differentiation in vitro. J Biosci Bioeng 103:412-419.
27. Nelson TJ, et al. (2008) CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 26:1464-1473.
28. Scherschel JA, Soonpaa MH, Srour EF, Field LJ, Rubart M (2008) Adult bone marrowderived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium. Mol Ther 16:1129-1137.
29. Murry CE, et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
30. Dai W, et al. (2007) Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 43:504-516.
31. Kehat I, et al. (2004) Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 22:1282-1289.
32. Smits AM, et al. (2009) Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 83:527-535.
33. Pillekamp F, et al. (2009) Physiological differences between transplanted and host tissue cause functional decoupling after in vitro transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 23:65-74.
34. Habeler W, et al. (2009) An in vitro beating heart model for long-term assessment of experimental therapeutics. Cardiovasc Res 81:253-259.
35. Entcheva E, Bien H (2006) Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution. Prog Biophys Mol Biol 92:232-257.
36. Aikawa R, et al. (2000) Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102:2873-2879.
37. Laflamme MA, et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024.
38. Sekine H, Shimizu T, Kosaka S, Kobayashi E, Okano T (2006) Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J Heart Lung Transplant 25:324-332.
39. Miragoli M, Gaudesius G, Rohr S (2006) Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 98:801-810.
40. Pillekamp F, et al. (2007) Force measurements of human embryonic stem cell-derived cardiomyocytes in an in vitro transplantation model. Stem Cells 25:174-180.
41. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT (2006) Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116:237-248.
42. Davis ME, et al. (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 103:8155-8160.
43. Mousses S, Kallioniemi A, Kauraniemi P, Elkahloun A, Kallioniemi OP (2002) Clinical and functional target validation using tissue and cellmicroarrays. Curr Opin Chem Biol 6:97-101.